Leprosy - 18/07/24
Doi : 10.1016/j.jaad.2024.04.019
Rohan Manoj, MBBS a, Shrishti Singh, MBBS a, Yash Buccha, MBBS a, Shubham Deokar, MBBS a, Banyameen Iqbal, MD (Pathology) b, Aayush Gupta, MD (Dermatology) a, ⁎ 
a Department of Dermatology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, India
b Department of Pathology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India
∗Correspondence to: Aayush Gupta, MD (Dermatology), Head of Department, Department of Dermatology, Venerology and Leprology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018, India.Department of Dermatology, Venerology and LeprologyDr. D.Y. Patil Medical CollegeHospital and Research CentreSant Tukaram Nagar, PimpriPuneMaharashtra411018India
Key words : bacterial infection, leprosy, mycobacterial infection
Plan
| Funding sources: None. |
|
| Patient consent: Written patient consents were obtained for the use of these images. |
|
| IRB approval status: Not applicable. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 91 - N° 2
P. 382-392 - août 2024 Retour au numéro
Article précédent
- Dermatology medications with the highest cost burden on Medicare Part D: Potential implications of the Inflation Reduction Act
- Annie I. Chen, Joe K. Tung, Laura K. Ferris
- JAAD Game Changers: Diet and psoriasis, part III: role of nutritional supplements
- Robert T. Brodell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?